By combining AI-powered accessibility intelligence with human-centered validation and enterprise implementation frameworks, AccessifyLabs and Accessibility Cloud are establishing a new global standard ...

Clearwater Analytics , the most comprehensive technology platform for investment management, today announced breakthrough embedded agentic AI capabilities within Beacon by CWAN, its enterprise risk ...

Rivian (RIVN) has officially started rolling out validation units of its highly anticipated R2 electric SUV from its factory in Normal, Illinois. CEO RJ Scaringe shared the news, confirming that the ...

“I just need you to validate my feelings.” It's a phrase therapists, partners, and friends hear constantly—and it reveals something fascinating about our cultural moment. Validation has become the ...

In 2018, the California state legislature set the goal of reaching net-zero carbon emissions by 2045 in the California Climate Crisis Act. In September of 2025, a team of Stanford researchers ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

LAS VEGAS—The American Heart Association is launching an AI Assessment Lab in partnership with Dandelion Health to validate predictive AI for cardiovascular conditions and related diseases. The group ...

Earlier this week, Microsoft patched a vulnerability that was flagged with the "highest ever" severity rating received by an ASP.NET Core security flaw. This HTTP request smuggling bug (CVE-2025-55315 ...

Following reports that Brooks Nader was romantically involved with tennis star Jannik Sinner, her sister revealed that the Sports Illustrated Swimsuit model is dating a tennis champ, but it’s not ...

A new AI tool reads lung cancer biopsy slides in under an hour, accurately predicting mutations and saving patients delays, costs and tissue loss, marking a turning point in precision cancer care.

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...